TET1 mutations as a predictive biomarker for immune checkpoint inhibitors in colon adenocarcinoma
Abstract Background The ten-eleven translocation 1 (TET1), which is essential for active DNA demethylation, plays a multifaceted role in the pathogenesis of colorectal cancer. The study has demonstrated the association of TET1 mutations with a high response to immune checkpoint inhibitors (ICIs) in...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2022-04-01
|
| Rangatū: | World Journal of Surgical Oncology |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1186/s12957-022-02581-7 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|